Macro Dragon: Is this Monday open different, or do we rally regardless? Macro Dragon: Is this Monday open different, or do we rally regardless? Macro Dragon: Is this Monday open different, or do we rally regardless?

Macro Dragon: Is this Monday open different, or do we rally regardless?

Macro 3 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon highlights the wk ahead, checks in on the Coronavirus as well as shares views strategically & tactically.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)



Macro Dragon:Is this Monday open different?


The Week Ahead…

  • Central bank wise, we have decision out of New Zealand (rates expected to be held at 1.00%) & Mexico (Rates expected to be cut to 7.00% from 7.25%). There is quite a bit of Fed speak, with Powell set to testify before the Senate banking Panel. Also on same theme Lagarde will be speaking before the EC. We’ll also be hearing from RBA’s Lowe & Norges Bank’s Olsen.
  • Econ wise, CPI & PPI out of China, alongside loan data are likely to be ignored given the focus on the virus. We do also have CPI & retail sales out of the US, that is likely to be very much not ignored. Lastly IP & Flash GDP data out of Europe will be key.
  • Lastly for WK 7, it will be interesting to see if the New Hampshire primaries (Tue Feb 11 US time) will be just a touch better than the slow-motion-train-crash that was the Iowa Caucuses – which likely resulted in Trump being the real winner & Peter-B getting some wind knocked out of his sail. Other candidates really starting to take aim at Peter-B.
  • The Macro Dragon Slam-dunk-presidential trade is for Sanders, Warren or Bloomberg to take Peter-B as VP, then its game over. At 38, he’d get max 4yrs as VP (if they win), then potentially 8yrs as President after.
  • Its also going to be a long US wkd towards end of this wk, as they got Trump day on Feb 17th (Presidents Day, can see all the liberals heading to work anyway – not! That would be pretty funny though).
  • Markets will continue to focus on the Virus… as ideally we should start to see numbers drop off in China… i.e. +2wks period incubation period is over given the excellent decision to extend the lunar new year holiday that technically started on Jan 24th. Its worth noting that as China gets back into business slowly this wk, a lot of companies are urging remote working initiatives for that can do so


2019-nCoV Update Mon Asia Mrn 10 Feb & Thoughts…

  • We’ve expanded our thoughts this wk with a combination of updates, potential scenarios around opportunities & risk surrounding the Novel Coronavirus (a.k.a. 2019-nCoV / Wuhan Coronavirus) on “Speechless…” Thu 6 Feb, on Wed 5 Feb, on Tue 4 Feb, start of WK 6 Mon 3 Feb, here on Fri 31 Jan, here on Thu 30 Jan, here on Wed 29 Jan & here on Tue 28 Jan.
  • Also on Fri 7th Macro Dragon also included the context piece & thoughts of how the virus eventually plays out – combination of burning itself out as summer kicks into the Northern Hemisphere (granted break-outs in Southern Hemisphere possible) and/or the more likely case that it just become another seasonal flu bug that has to be contended with – similar to the US swine flu virus that broke out in 2009 & ended with over 60m Americans infected, over 270m globally & likely a conservative c. +300,000 deaths. Two key differences between that & now: 1. It was c. 10yrs ago when the social media volume was at 1x rather than today’s 11x and it was the US & not China – which lets be honest, western media & governments like to beat up relative to their own peers/neighbors.
  • Key risk to this view is that there is something a lot more dangerous about this virus than we know – which again given that we are seeing treatments & infections abroad, is likely a low probability. As to the risks of mutations, that a risk in all viruses & the truth is they are constantly mutating – it’s the extent of the mutation. For context according the the US Centers for Disease Control & Prevention, so far in this flu season in the US 19m have been infected, 180,000 had to end up in hospital & 10,000 have died.
  • Whilst the markets –  & China Equity Markets in particular – rallied tremendously last wk with new highs being seen in the S&P, the Macro Dragon remains skeptical at best on China/Asia Equity rally & would be bearish vs. having a long bias again the US. Again as the Macro Dragon has said from the first wk of covering the outbreak, we are back in a world of US outperformance vs. RoW, with a reflexivity twist. Strategically, one cannot own enough US duration – as all roads lead to a Fed that will need to cut. Tactically, it’s been a dice game to KVP, where if you are not staring at the screens all day, you can be in & out of profit on being either long or short. Its not to say the opportunities are not there – there always are opportunities (KVP totally missed the move by MAS & the weaker SGD), yet you need to be on point through all the regional trading sessions – and/or focus on an event that no one else is paying attention to.

Quick update & thoughts on the Virus since the Fri check in:

  • China slowly starts to come back to work this wk – albeit it could be weeks, potentially months in some cases before we are back to the production in the economy firing on all engines.
  • As of this Mon 10 morning, the China Figures we are getting are at c. 40,300 confirmed cases, +900 deaths & +3,000 recovered.  
  • Out of China the countries with confirmed cases over 10 are:
  • Japan 96,
  • Singapore 43
  • Hong Kong 36
  • Thailand 32,
  • South Korea 27
  • Taiwan 18
  • Malaysia 17
  • Australia 15
  • Germany 14
  • Vietnam 14
  • United States 12
  • France 11
  • Macau 10


Below bears a re-read or initial read if you missed previously…

This is a replay segment from Fri’s Macro Dragon – again due to its importance, key part to bear in mind here is what time-horizon are you playing & do your horizons/views match your exposure

Note these were prior to the huge melt-up that we had in wk #6 (Last wk). So question is, does it play out this into next wk… or does the bullish euphoria continue. Is there just too much liquidity in the system, for markets to care about the deflationary hit that China is going to take and/or are markets, just looking through all this as just a hiccup before we get China stimulus?

[From WK 5]

  • Here are a few other thoughts around the virus from the rest of the dream team at SaxoStrats – Key summary as captured by our CIO & Chief Strategist Steen Jakobsen, the near-term deflationary shock of the virus is not yet priced into markets, the economy, policy makers & companies – Jakobsen is envisaging a potential scenario where the Fed cuts 3x this year! Currently for the Mar 18, Apr 29 & Jun 10 meetings the implied probability of a Fed Cut (it was hikes prior to the mtg earlier this wk) are 14%, 28% & 55%.

Have a fantastic, gratitude & abundant filled wkd ahead everyone, stay healthy as well as keep your mind open to profitable & abundant opportunities. Life happens for us, not to us.  




Some Anchor Pieces from #SaxoStrats:


The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

Saxo Markets
40 Bank Street, 26th floor
E14 5DA
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo Markets is a registered Trading Name of Saxo Capital Markets UK Ltd (‘SCML’). SCML is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo Markets assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992